Yu Miyazaki

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 164 citations

Bone Disease, Osteopathy, Loft Extension Study +10

Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2

Yu Miyazaki, Hiroaki Adachi, Masahisa Katsuno et al. · Nature Medicine · 2012 · 150 citations

Immunology, Rna Biology, Viral Delivery +8

Identification and Characterization of GABAA Receptor Autoantibodies in Autoimmune Encephalitis

Toshika Ohkawa, Shin’Ichiro Satake, Norihiko Yokoi et al. · Journal of Neuroscience · 2014 · 124 citations · Full text

Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer

Takayuki Sumiyoshi, Kei Mizuno, Toshinari Yamasaki et al. · Scientific Reports · 2019 · 72 citations · Full text

The Expression Profile of Phosphatidylinositol in High Spatial Resolution Imaging Mass Spectrometry as a Potential Biomarker for Prostate Cancer

Takayuki Goto, Naoki Terada, Takahiro Inoue et al. · PLoS ONE · 2014 · 71 citations · Full text